Concurrent delivery of paclitaxel and 17-AAG via micellar nanocarriers

被引：0
|
作者：
Katragadda, Usha [1 ]
Fan, Wei [1 ]
Tan, Chalet [1 ]
机构：
[1] Mercer Univ, Atlanta, GA USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-5698
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5698
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Effects of salinomycin and 17-AAG on proliferation of human gastric cancer cells in vitro
    Zhang, Zuwen
    Zhao, Jumei
    Mi, Zhikuan
    Pang, Qiuxia
    Wang, Aihong
    Chen, Meini
    Liu, Xiaobin
    Wei, Xiaoli
    Liu, Tao
    MOLECULAR MEDICINE REPORTS, 2017, 16 (02) : 1063 - 1070
  • [32] Gene expression profiles of drug action and resistance to 17-AAG in breast cancer
    Magdalena, Zajac
    Fernandez, Maria
    Benitez, Javier
    Martinez-Delgado, Beatriz
    CANCER RESEARCH, 2009, 69
  • [33] Polymeric Micellar Nanocarriers for Gene and Oligonucleotide Delivery
    Kataoka, Kazunori
    MOLECULAR THERAPY, 2013, 21 : S135 - S135
  • [34] Imatinib in combination with 17-allylamino-17-demethoxy-geldanamycin (17-AAG) for treatment of chronic myelogenous leukemia
    Topaly, J
    Schad, M
    Zeller, W
    Fruehauf, S
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 72 - 72
  • [35] Combination of Rapamycin, CI-1040, and 17-AAG Inhibits Metastatic Capacity of Prostate Cancer via Slug Inhibition
    Ding, Guanxiong
    Feng, Chenchen
    Jiang, Haowen
    Ding, Qiang
    Zhang, Limin
    Na, Rong
    Xu, Hua
    Liu, Jun
    PLOS ONE, 2013, 8 (10):
  • [36] Effects of the inhibition of NPM-ALK kinase activity by 17-allylamino-17-demethoxygeldanamycin (17-AAG).
    Turturro, F
    Frist, AY
    Arnold, MD
    BLOOD, 2001, 98 (11) : 465A - 465A
  • [37] A phase I trial of 17-allyl-amino-geldanamycin (17-AAG) in patients with advanced cancer
    Goetz, M
    Toft, D
    Reid, J
    Sloan, J
    Atherton, P
    Adjei, A
    Croghan, G
    Weinshilboum, R
    Erlichman, C
    Ames, M
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S54 - S55
  • [38] 17-AAG suppresses growth and invasion of lung adenocarcinoma cells via regulation of the LATS1/YAP pathway
    Ye, Xiang-Yun
    Luo, Qing-Quan
    Xu, Yun-Hua
    Tang, Nai-Wang
    Niu, Xiao-Min
    Li, Zi-Ming
    Shen, Sheng-Ping
    Lu, Shun
    Chen, Zhi-Wei
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2015, 19 (03) : 651 - 663
  • [39] 17-AAG potentiates the apoptotic action of the antileukemic drug arsenic trioxide.
    Pelicano, H
    Carew, JS
    McQueen, TJ
    Andreeff, M
    Keating, MJ
    Huang, P
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9159S - 9159S
  • [40] Telomerase as a molecular target for 17-AAG: Exploiting the tumor to improve therapeutic index
    Locke, J
    Thompson, N
    Allan, J
    Pandita, T
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S357 - S357
12345